Alecta Tjanstepension Omsesidigt cut its position in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 22.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,721,965 shares of the technology company’s stock after selling 502,000 shares during the quarter. AMETEK makes up about 1.4% of Alecta Tjanstepension Omsesidigt’s holdings, making the stock its 20th biggest position. Alecta Tjanstepension Omsesidigt’s holdings in AMETEK were worth $323,506,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AME. Parallel Advisors LLC boosted its stake in shares of AMETEK by 2.0% in the 3rd quarter. Parallel Advisors LLC now owns 2,766 shares of the technology company’s stock worth $520,000 after buying an additional 53 shares during the last quarter. Biltmore Wealth Management LLC lifted its holdings in AMETEK by 1.1% during the third quarter. Biltmore Wealth Management LLC now owns 4,771 shares of the technology company’s stock worth $897,000 after acquiring an additional 54 shares during the period. Brooklyn Investment Group lifted its holdings in AMETEK by 3.2% during the third quarter. Brooklyn Investment Group now owns 1,735 shares of the technology company’s stock worth $326,000 after acquiring an additional 54 shares during the period. Cim LLC boosted its position in AMETEK by 0.7% in the third quarter. Cim LLC now owns 7,645 shares of the technology company’s stock worth $1,437,000 after purchasing an additional 56 shares during the last quarter. Finally, HighPoint Advisor Group LLC grew its stake in AMETEK by 3.0% in the 3rd quarter. HighPoint Advisor Group LLC now owns 2,070 shares of the technology company’s stock valued at $389,000 after purchasing an additional 60 shares during the period. Hedge funds and other institutional investors own 87.43% of the company’s stock.
Insider Buying and Selling
In other news, VP Thomas M. Montgomery sold 6,388 shares of the business’s stock in a transaction on Monday, December 22nd. The shares were sold at an average price of $205.05, for a total transaction of $1,309,859.40. Following the completion of the transaction, the vice president directly owned 22,116 shares in the company, valued at $4,534,885.80. The trade was a 22.41% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is currently owned by insiders.
AMETEK Stock Down 1.4%
AMETEK (NYSE:AME – Get Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The technology company reported $2.01 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.07. The company had revenue of $2 billion during the quarter, compared to analyst estimates of $1.94 billion. AMETEK had a net margin of 20.00% and a return on equity of 16.55%. AMETEK’s revenue was up 13.4% compared to the same quarter last year. During the same period last year, the business earned $1.87 earnings per share. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. On average, equities analysts predict that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.
AMETEK Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Monday, March 16th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Monday, March 16th. This is a positive change from AMETEK’s previous quarterly dividend of $0.31. AMETEK’s payout ratio is 21.25%.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on AME shares. Morgan Stanley raised their target price on AMETEK from $215.00 to $235.00 and gave the company an “equal weight” rating in a research report on Thursday, March 12th. Truist Financial set a $265.00 price target on shares of AMETEK in a research report on Wednesday, February 4th. Melius Research set a $235.00 price objective on shares of AMETEK in a report on Monday, January 5th. Wall Street Zen raised shares of AMETEK from a “hold” rating to a “buy” rating in a research report on Sunday, February 22nd. Finally, TD Cowen reiterated a “buy” rating on shares of AMETEK in a research note on Tuesday, February 3rd. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $244.82.
Get Our Latest Stock Analysis on AMETEK
About AMETEK
AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.
The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.
Featured Stories
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
